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Protem kmases are mvolvcd m signal transduction m human blood platelets A number of rcnaturable protern kmases have Increased m vitro 
actlvmes compared to controls due to covalent modlficatlons when Intact platelets are activated by thrombm The effect of the platelet mhlbrtor 
l%hydroxywortmannm (HWT) on these protem kmases was investigated m Intact platelets and m vitro HWT mhlblts the Increase m actlvny of 
these pro&m kmases but It does not interact chreLtly with their catalytic subumts We conclude that HWT blocks a step m slgnal transduction which 
IS necessary to activate these protem kmdses via covalent mochficat~ons 
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1. INTRODUCTION 
Stlmulatlon of platelets with thrombm mduces the 
GTP-dependent activation of phosphohpase C [I] 
which cleaves membrane-bound phosphatldyhnosltol 
blsphosphate (PIP& to produce the second messengers 
mosltol 1,4,5-tnsphosphate (la,) and dlacylglyccrol 
(DAG). IP3 triggers the release of calcium from the 
storage granules mto the cytosol [2] while DAG actl- 
vates protem kmase C [3] that phosphorylates a number 
of substrates [4-S]. Other pathways of platelet actlva- 
tion are less well characterized and may also Include 
phosphorylatlon cascades. 
The actlvlty of a group of protein kmascs could be 
restored by renatuiatlon after electrophoresls and 
transfer to PVDF membranes [9] Kmase actlvlty was 
monitored with [y-‘*P]ATP Bands on the blots were 
detected by autorddiography Phosphoserme and phos- 
phothreonme were predommantly labelled and analysis 
of the phosphorylated plotem spccles revealed that with 
most of the protein kinases, bovine serum albumm and 
the kmases themselves (variable amount of autophos- 
phoryldtlon) contained most of the 32P-Iabel [ 101. Some 
of these protem kmases show higher m vitro actlvltles 
on the blots when Intact platelets were activated dnd 
therefore may somehow be involved m slgnal transduc- 
tion pathways The changes in activity ale most prob,+ 
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bly due to covalent modlficatlons as they arc conserved 
during the denaturatlon- and renaturatlon-treatment 
17-Hydroxywortmannm (HWT) IS a derlvatlve of the 
sterol-like fungal metabohte wortmannm [ 111 It mhlbl- 
ted tesplratory burst and secretion m neutrophlls with- 
out directly affectmg KC [IL!]. Since HWT shows rela- 
tlticly specific effects on platelet actlvatlon (von Tschar- 
ner, V and Clemctson, K J., submitted), renaturatlon 
of blotted proteins was used to lnvcsklgate Its effects on 
the activation m Intact platelets and m vitro actlvltles 
of the renaturable and covalently modified protem 
kmases from human blood platelets m order to correlate 
these with other platelet reactlons 
2, MATERIALS AND METHODS 
2 i Murerrals 
Apyrdse, bovme serum albumm (fractron V and fatty acid free, 
frdctlon V), phot bol mynstyl acetate (PMA), lonomycm and the pre- 
stamed molecular mass markers were from Sigma, St LOUIS, MO 
Thrombm was from Merck, Zurich Iloptost was kmdly donated by 
Schermg AG, Zunch HEPES wds from Calblochem, Lucerne Guam- 
dme-HCI was from Fluka, Buchs and Nomdet P-40 was from Gregg, 
Bcrne [$‘P]ATP (3000 Cl/mmol) was from Amersham International, 
England The PVDF membranes (Immobllon-P) were from M&pore, 
Bedford, MA HWT, { 1,7,8,9,9a,l lb-octahydro-I I-acetoxy-9-hy- 
droxy-l-(methoxymcthyl)-9d,11 b-dlmethyl-3W,6bH-Jltro[4,3,2- 
dc]rt&rro[4,5- h][2]6c/r:ollyra/l-3,6-d~on} a dthe Inactive wortmannm 
der~vdlive IWT (6b,7,9d,10,11.I 1b-hexahydro-5-hydroxy-4-hydroxy- 
mcthylcn-1-methoxymcthyl-9~1,1 I b-dlmcthyl-I ~I,6H-/rldoto[~,~-h][2]- 
herr=o/?llran-3,6,9(4H,8H)-trloli} were supphcd by Dr T G Payne, 
Prcchnrcai Rcscdrch, Sdndol Ltd , Bdsk, Swltzcrldnd 
Buffy co.lts wcrc obtdmed from the SWISS Red Cross m Bcrne (FDA 
four bdg rystcm) dpproxundtcly I5 h dftcr collectlon Buffy coat dllu- 
tlon buffer (0 1 volume) was ad&d togwc an end conccntratlon of 10 
mM sodium clt!dtc .md 0 IS U/ml Jpyrdsc and the suspension wds 
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centrtfuged at 15Oxg for 15 mm The platelet-rich plasma was acldlficd 
to pH 6 5 with 150 mM cltnc acid, lloprost was added to an end 
concentration of I @ml, and centrlfugatlon at 5OOxg for IS mm 
pelleted the platelets The platelets were washed twice with 100 vols 
of 137 mM NaCI, I I mM glucose, I1 mM sochum citrate. 0 2 U/ml 
apyrase, 0 25% ES& pH 6 5. and then :esuspended m 137 mM NaCl. 
2 mM KCI, I mM MgCI,, 1 mM CaCI,. 0 4 mM NaH#O,. 5 6 mM 
glucose, 5 mM HEPES, I U/ml dpyrase pH 7 5 to an end concentra- 
tlon of IO’ platelets per ml Experiments were performed at 37°C 
HWT was added from stock solutions III Me,SO toyleld a final Me2S0 
concentration of 0 I%, which did not change the pattern of phospho- 
rylatlon m the renatured kmases 
Samples were solublhzed mimedidtely m SDS-PAGE sample buffer 
at a concentration of 2 3% SDS, 0 1% dlthlothreltol, 0 I mM EDT& 
62 5 mM Trls, 10% glycerol, pH 6 8, vortexed and bolled for 2 mm 
Separation of platelet proteins m 7 5% po!yacrylamlde gels [13] and 
the transfer to PVDFmembranes were asdescribed [I41 RendtUratiOn 
and kmase reacttons were performed according to Ferrell and Martin 
[IO] Tkc X-ray films were analysed on a DD2 dcnsltometer tram Kipp 
8r Zonen connected to a chart recorder 
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After rendturatton dnd blockmg. sections of the blots were treated 
with HWT m 30 mM Trls. 10 mM MgCI:. 2 mM MnCI,, pH 7 5 for 
IO mm at room temperature They were washed onrz with the sdmc 
buffer without HWT dnd then incubated with the kmase reactlon 
buffer [IO] 
3. RESULTS 
Washed human platelets were premcubated with dlf- 
ferent concentrations of HWT for 10 mm and then stl- 
mulated with thrombm (Fig I). Blots from untreated 
control or thrombm-stimulated platelets showed 
patterns of labelled bands slmllar to those reported 
earlier [lO] A combmatlon of the phorbol ester PMA 
and ronomycm induced the actlvltles of the protein 
kmases slmllar to that Induced by thrombm (not 
shown). Premcubatlon of unstlmulated control platelets 
with HWT had no effect on the actlvittes of the rena- 
turated protein kmases (Fig IA) HWT premcubatlon 
mhrbrted the increase of activity of PK 48, PK 52, PK 
0 
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Fig I Effw of HWT tredtmcnt and thrombln rtimulatlon In mt.ict pl~tclc~s on the in vitro nctivitic\of the rcndluidblc prolcm kmdscs flom hum.m 
platelets Autor.ldlogldm of PVDF-mcmbrancs with iciidturdtcd protcm\ I,lbcllcd 111 vitro with [y-“P]hTP from J. typical cupcnmcnt whcrc pl,liclct\ 
wcrc prcmrubatcd for IO I~II with dlffclcnt cdnccntrdtlon$ of HW r (A) Shows unstimuldtcd pldtclcts ptcmLubalcd with and without HWT (B) 
Show5 pldtclcts ,rctlv,ltcd with I U/ml thrombln The 0 umc 5dmplcs ucrc ldkcll JllSt before the dddltion of lhrombln. then the other 5dmplcs were 
taken after timca ds mdlcatcd and dll wcrc trwtcd .I+ dc<cl~bcd 111 Mdtcrldls and Mcthads The \tiniuldtioii~ wcrc pciformcd with wdyhrd pl.~tclcts 
from the T.I~L’ buffy co.~t All the blots wc~c tlc&zd the s.itnc wny dnd dulor.idlogrdphfd togclhcr on lhc \dmc lilni Mnlccul,lr md\‘i mdl kcrs dlc 
mdIcdtcd 111 klloddltons 
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time [mfnutes] 
FIN 2 Kmetics of PK 60 a&v&on Dcnsltometrlc dndlys~s of the 
autoradlograms of several smnldr evpernnents of the achvny of PK 
60 The amount of processed “P wdb measured as peak surfdces 
relatwe to the control V~IUCS at 0 time th‘lt were set to 100 The 
symbols dre i? control. n=4. ‘7 HWT IO-’ M alone, ~2, An HWT 
IO-’ M. n=1, b HWT IO-’ M, r1=2, both stlmuldted wtth thlombm I 
U/ml o thrombm I U/ml, n=4 
56. PK GO. PK 64 and PK 170 after thrombm treatment 
(Pig IB) The mactlve wortmannm derlvatlve (IWT) 
had no effect on the actlvltles of the renaturated protein 
kinascs flom elthel unstlmulnted control platelets or 
from thlombm-stimulated platelets (not shown) The 
acilvltles of PK 82, PK 86 and PK 94 were little dffected 
when platelets were activated with thrombm I-IWT did 
not change this The actwlty of PK 150 after thlombm 
strmulatlon was Increased although the difference was 
very small Thus was not mhlblted by HWT. PK 150 
actlvlty was also increased by PMA nlone and not af- 
fec:od by HWT (not shown) 
PK 60 was the strongest labelled band detected m this 
k:nase assay method 111 platclcts and densltometl~ dna- 
lysls of the relative mtensltles of these bands (Fig 2) 
revedlcd that the I& of HWT was approximately lo-’ 
M At 10e5 M HWT the lnclease m actlvlty was comple- 
tcly InhIbIted At HWT concentrations of IOU’ M and 
lowc~, the time course of the kindse activity followed 
roughly the time course of thlombin activdtlon (data 
not shown. rt=l). 
To mvcstlgate whether HWT directly affected the 
protein kmases, the renaturated proteins on the mem- 
branes were subJected to In vltio HWT treatment with 
dlffelent concentrations dfte1 rendturatlon dnd blockmg 
and before incubation with the rddlodctive ATP (Fig 
3). HWT had no effect 311 dny renaturdble protem kl- 
nasc m vitro. The dlffelences m the actlvltles of the 
renaturatcd proteln kindscs flom control and from 
thlornbm ttcatcd platelets wele still conscrvcd, 
4 DISCUSSION 
From two previous hcnc5 of cxpcrmicnts the rcnatu- 
ruble protcln kin,lscs from platclcts could ahc,ldy be 
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Fig 3 Comparison of HWT-treatment m Intact platelets dnd in vitro 
Platelets were premcubated with HWT at different concentrations as 
Indicated above for 10 mm They were then treated wtth (T) or wlthout 
(C) thrombm at a concentration of I U/ml for2Os After renaturcltlon 
and blockmg the four sectlons of the blot were treated with different 
concentrations of HWT In v11lo for IO mm as mdlcated on the’m vitro’ 
side of the top hne The left pal t of the blot wac treated wrth buffer 
alone All four pieces were then tlcatcd with 50,KYml [y-12P]ATP for 
30 mm Autoladlograms wcrc prepared from the washed and dried 
blots Moleculdr mass mdrkcrs xc mdlcdted III kllodaltons 
dlvlded mto different groups [IO] according to the chan- 
ges m lhelr renaturdted m vitro actlvlty with different 
platelet actlvatols m Intact platelets PK 52, PK 56. PK 
60, PK 64 and PK I70 were activated when platelets 
were treated with a combmatlon of phorboi ester and 
lonophore mdlcatmg their possible mvolvement m sag- 
nal tlansductlon downstream of PIP,-breakdown. PK 
52 and PK 64 are most probably activated by phospho- 
rylallon as then dctivatlon 1s mhlblted by the protem 
kmase mhlbltor staurosporme and PK 52, PK 60. PK 
150 and PK 170 ale acllvatcd by dephosphorylatlon or 
another mechanism since their activation was enhanced 
by staurosporme [14]. 
In neutlophlla HWT lnhlblted the fMLP-induced re- 
splratoly burst at a concentration of IO-” M but the 
PMA-Induced butst wds not affected suggestmg that 
HWT does not mhlblt PKC directly dnd it does not 
lntelfele with the phosphohpase C medrated rise m m- 
tracellular calcium concentration (via IPI) and therefore 
a novel slgnal transduction pathway was proposed [12]. 
There IS evidence that DAG productlon and the resul- 
ting PKC actlvatlon IS not only phospholipase C de- 
pcndent and the dctlvation of phosphohpase D to pro- 
duce DAG via dnother pathway to fully activate PKC 
was ploposcd [15] This lcacls to the speculation thdt 
PKC actlvatton ts blocked mdlrectly by HWT by redu- 
cmg DAG productlon via the other pathway Smce m 
platelets HWT mhlblts aggregation and pleckstrm 
phospharylatlon (van Tscharnel, V and Clemetson, 
K J , submitted) dnd the mcredsc 111 actlvlty of several 
Ser/Thr protcm kmases (this paper) &it d comparable 
conccntlatlon (IO-’ M) to that effcctlvc m ncutrophils. 
a similar slgndl transduction pdthway might be affected 
that lends to the activation of protein kmases DAG IS 
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not enough to activate the renaturable protem kmases 
smce PMA alone only stimulates one of them (PK 150) 
and they are therefore not activated via PKC alone. The 
way in which PKC Itself 1s activated suggests that It 1s 
not detected m this assay system, as It requires at least 
phosphatldylserme and DAG for actlvatlon 1161. As all 
the protem kmases inhibited by WWT (PK 48, PK 52, 
PK 56, PK 60, PK 64 and PK 170) are affected to 
roughly the same extent (Ftg I) they may all be mvol- 
ved m a later phase of platelet actlvatlon HWT blocks 
a step m signal transduction which IS necessary to actl- 
vats these protein kmases via covalent modlficatlons. It 
was suggested that this may be a G-protem dependent 
step leadmg to phosphohpase I3 actlvatlon [17] 
While staurosporme directly blocks the protem kma- 
ses m a general way but cannot prevent their actlvatlon 
and even mduccs the actlvatlon of PK 52, PK 60 and 
PK 170 directly [14], HWT probably mhlblts the mltla- 
tlon of the pathway leading to their actlvatlon The 
above results Indicate that NWT 1s a useful tool for 
dlfferentlating between early and late signal transduc- 
tion events. Protem kmases may be involved m the 
regulation of other enzymes or receptors by phospho- 
rylatlon and together with phosphatases may bc re- 
sponsible for amphfisatlon or fine tunmg of signals. 
Smce aggregation of platelets is not completely in- 
hibited by staurosporme [ 1 g] the actlvatlon of PK 52, 
PK 56, PK 60, PK 64 and PK 170 1s not suffictent to 
lead to platelet aggregation. Their mhlbmon by WWT 
correlates well with the mhibmon of the late phase of 
platelet actlvatlon mcludmg aggregation. Other stml- 
larlties are found when the kinetics of activation of these 
kmases are compared to the increases m Tyr-phospho- 
rylatlon of platelets. Tyr-phosphorylatlon increases also 
in a group of proteins in platelets 3 mmutes after 
thrombm stlmulatlon [19]. Although It remams un- 
resolved whether the renaturable protem kmases are 
mvolved m the signal transduction leadmg to aggrega- 
tlon and secretion the results obtamed here suggest hat 
actlvatlon of these protem kmases goes m parallel with 
these processes. 
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